“In some instances, clinicians are getting a constant stream of alerts that aren’t appropriate for their patient, leading them to disregard the alerts,” said senior author James Hoffman, PharmD, St. Jude’s chief patient safety officer. “This type of alert fatigue can lead to patient safety concerns.”
For the study, the researchers collected input on the EHR’s drug interaction alerts from three sources: a validated survey instrument, an advisory group of St. Jude clinicians and data within the EHR that captured which alerts clinicians most often ignored or overrode.
Overall, the research team made 26 changes that affected 47 percent of alerts. They also found that alert overrides decreased by 40 percent.
Changes to the system included removing unnecessary alerts and adding context to existing alerts to make them more useful for clinicians.
More articles on clinical leadership & infection control:
Researchers create blood test to determine patients’ pain severity
Vaccine hesitancy linked to community norms, researcher says
Pennsylvania health system collaborates with healthcare trust to improve care
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
